Holen Sie sich die Stockscreener-App
378.04
2.95%
-11.49
Handel nachbörslich:
390.95
12.91
+3.41%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HCA?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$389.53
Offen:
$386.98
24-Stunden-Volumen:
1.30M
Relative Volume:
0.86
Marktkapitalisierung:
$87.79B
Einnahmen:
$71.59B
Nettoeinkommen (Verlust:
$5.78B
KGV:
16.81
EPS:
22.49
Netto-Cashflow:
$4.95B
1W Leistung:
+1.03%
1M Leistung:
-1.08%
6M Leistung:
+26.97%
1J Leistung:
+18.25%
1-Tages-Spanne:
$377.42
$386.98
1-Wochen-Bereich:
$375.00
$391.00
52-Wochen-Spanne:
$289.98
$417.14
Hca Healthcare Inc Stock (HCA) Company Profile
Firmenname
Hca Healthcare Inc
Sektor
Branche
Telefon
(615) 344-9551
Adresse
ONE PARK PLZ, NASHVILLE, TN
Vergleichen Sie HCA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HCA
Hca Healthcare Inc
|
378.04 | 87.79B | 71.59B | 5.78B | 4.95B | 22.49 |
|
FMS
Fresenius Medical Care Ag Adr
|
28.32 | 16.81B | 20.92B | 666.06M | 1.85B | 1.1422 |
|
THC
Tenet Healthcare Corp
|
172.22 | 14.54B | 20.52B | 1.46B | 1.41B | 15.12 |
|
EHC
Encompass Health Corp
|
118.88 | 12.02B | 5.51B | 494.70M | 386.40M | 4.84 |
|
UHS
Universal Health Services Inc
|
184.47 | 11.13B | 16.08B | 1.20B | 1.06B | 17.82 |
Hca Healthcare Inc Stock (HCA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-29 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2025-04-15 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-12-17 | Fortgesetzt | JP Morgan | Neutral |
| 2024-11-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-11-22 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-09-03 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2024-01-04 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-12-11 | Herabstufung | Goldman | Buy → Neutral |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-04-19 | Fortgesetzt | JP Morgan | Neutral |
| 2022-07-06 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2022-03-29 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-01-10 | Fortgesetzt | Citigroup | Buy |
| 2021-12-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-24 | Eingeleitet | UBS | Buy |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-08-12 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-05-13 | Fortgesetzt | Citigroup | Neutral |
| 2021-04-26 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-15 | Eingeleitet | Goldman | Buy |
| 2020-12-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-09-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-07-13 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-06 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-07-10 | Hochstufung | Goldman | Neutral → Buy |
| 2019-04-23 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2018-11-16 | Eingeleitet | UBS | Buy |
| 2018-03-23 | Fortgesetzt | Mizuho | Buy |
| 2018-01-03 | Eingeleitet | Goldman | Neutral |
| 2018-01-03 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-12-20 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2017-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2017-11-30 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2017-11-06 | Bestätigt | Citigroup | Neutral |
| 2017-11-01 | Bestätigt | Mizuho | Buy |
| 2017-07-26 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-06-28 | Eingeleitet | Argus | Buy |
Alle ansehen
Hca Healthcare Inc Aktie (HCA) Neueste Nachrichten
NC Panel Rejects HCA Unit's Appeal Over Rival Project Award - Law360
Morgan Stanley Upgrades HCA Healthcare (HCA) PT to $410, Keeps Equal Weight Rating - MSN
HCA Healthcare Defeats Whistleblowers’ Privacy Fraud Lawsuit - Bloomberg Law News
Will Regulatory Concerns Take a Backseat to Tariff Implications for HCA Healthcare (HCA)? - Insider Monkey
Why HCA Healthcare (HCA) is a Top Value Stock for the Long-Term - Yahoo Finance
Healthcare Worker's Wage Collective 'Amorphous,' HCA Says - Law360
HCA Healthcare stock price target reiterated at $444 by Cantor Fitzgerald - Investing.com
HCA Healthcare Climbs 3.6% After Key Trading Signal - Benzinga
HCA Healthcare Awards of Distinction at EIRMC - Idaho State Journal
The Boss: Cindy Bergmeier is always up to explore new places - The Business Journals
Why HCA Healthcare, Inc. (NYSE:HCA) Could Be Worth Watching - Yahoo Finance
When the Price of (HCA) Talks, People Listen - news.stocktradersdaily.com
HCA Healthcare, Inc. (NYSE:HCA) Q2 2024 Earnings Call Transcript - MSN
HCA Florida Memorial opens head and neck practice - Jacksonville Daily Record
Samuel Hazen: 100 Most Influential People in Healthcare 2024 - Modern Healthcare
HCA Healthcare Establishes $4 Billion Commercial Paper Program - Global Legal Chronicle
8 Best Inexpensive Stocks to Buy Right Now - Insider Monkey
Ex-Dividend Reminder: DTE Energy, HCA Healthcare and Bruker - Nasdaq
Columbia Hospital Corporation - Britannica
HCA Healthcare Insiders Sold US$12m Of Shares Suggesting Hesitancy - Yahoo Finance
HCA Healthcare (HCA) Launches $4 Billion Commercial Paper Progra - GuruFocus
HCA Healthcare Launches $4 Billion Commercial Paper Program - TipRanks
HCA Healthcare (HCA) Stock Declines Over 1.2%, Continuing a Short-Term Downtrend - Daily Chhattisgarh News
HCA FLORIDA MEMORIAL HOSPITAL RECEIVES COMPREHENSIVE STROKE CENTER CERTIFICATION FROM DNV - southfloridahospitalnews.com
HCA Healthcare (NYSE:HCA) Given New $410.00 Price Target at Morgan Stanley - Defense World
HCA Healthcare (HCA): Analyst Insights and Market Prospects | HC - GuruFocus
Is HCA Healthcare Stock Outperforming the Nasdaq? - MSN
HCA, Tenet upgraded at Wells Fargo on receding policy risks for hospitals - MSN
HCA Healthcare Inc (HCA) Trading Down 3.52% on Jun 9 - GuruFocus
HCA Healthcare (HCA) Price Target Raised by Morgan Stanley | HCA Stock News - GuruFocus
Celebration showcases new HCA Florida Sarasota Doctors Hospital free-standing ER in Venice - Sarasota Herald-Tribune
HCA Healthcare Options Trading: A Deep Dive into Market Sentiment - Nasdaq
Sammie Mosier: Most Influential Clinical Executives 2025 - Modern Healthcare
HCA Healthcare (HCA) Price Target Increased to $410 by Morgan St - GuruFocus
Here's How Much a $1000 Investment in HCA Healthcare Made 10 Years Ago Would Be Worth Today - Yahoo Finance
Morgan Stanley Adjusts Price Target on HCA Healthcare to $410 rom $355, Maintains Equalweight Rating - marketscreener.com
HCA Florida Healthcare doctor discusses what it means to be a trauma center, summer safety - WEAR-TV
Why HCA Healthcare (HCA) is a Top Momentum Stock for the Long-Term - sharewise
HCA Healthcare, Inc. (NYSE:HCA) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
Is HCA Healthcare Stock Outperforming The Nasdaq? - Barchart.com
HCA Worker Wants Collective Status In Time-Rounding Suit - Law360
Here's Why HCA Healthcare (HCA) is a Strong Growth Stock - Yahoo Finance
Leerink Partners Adjusts HCA Healthcare Price Target to $420 From $390 - marketscreener.com
HCA Healthcare (NYSE:HCA) Given New $416.00 Price Target at Barclays - Defense World
Barclays Raises Price Target for HCA Healthcare (HCA) | HCA Stock News - GuruFocus
Trend Tracker for (HCA) - news.stocktradersdaily.com
Barclays Adjusts Price Target for HCA Healthcare to $416 | HCA S - GuruFocus
Barclays Adjusts HCA Healthcare Price Target to $416 From $366, Maintains Overweight Rating - marketscreener.com
Barclays Adjusts Price Target for HCA Healthcare to $416 | HCA Stock News - GuruFocus
Wells Fargo Upgrades HCA Healthcare (BMV:HCA) - Nasdaq
Finanzdaten der Hca Healthcare Inc-Aktie (HCA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):